Published in Springer Semin Immunopathol on January 01, 2005
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. Cancer Ther (2008) 1.22
IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity. J Immunol (2010) 0.97
Recent advances in dendritic cell biology. J Clin Immunol (2005) 0.92
Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin Exp Immunol (2006) 0.87
Immunotherapy for advanced prostate cancer. Rev Urol (2007) 0.83
The role of molecular imaging in the development of dendritic cell-based cancer vaccines. Eur J Nucl Med Mol Imaging (2005) 0.83
A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology. J Immune Based Ther Vaccines (2008) 0.80
Dendritic cells and the control of immunity. Nature (1998) 56.54
Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol (2003) 15.51
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A (2003) 10.71
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol (1999) 7.60
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 6.03
The central role of CD4(+) T cells in the antitumor immune response. J Exp Med (1998) 6.02
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med (2003) 5.96
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol (2003) 5.90
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol (2004) 5.73
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res (1999) 5.41
Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol (2000) 5.13
Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol (2000) 4.98
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med (1998) 4.80
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med (2001) 4.78
Induction of tolerance by IL-10-treated dendritic cells. J Immunol (1997) 4.65
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med (2003) 4.64
T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today (1999) 4.49
A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity (1999) 3.84
Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev (2001) 3.70
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol (2003) 3.69
The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol (1998) 3.68
All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res (2003) 3.45
Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med (2001) 3.39
Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res (2001) 3.29
CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity (2000) 3.07
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res (2004) 2.91
Sensing pathogens and tuning immune responses. Science (2001) 2.73
Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother (2003) 2.65
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells. J Exp Med (1985) 2.65
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J Immunother (2002) 2.65
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc Natl Acad Sci U S A (1999) 2.60
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med (2002) 2.55
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med (2002) 2.37
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood (2002) 2.30
Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci U S A (1995) 2.27
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol (2001) 2.24
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med (2000) 2.23
Expression and function of OX40 ligand on human dendritic cells. J Immunol (1997) 2.13
Dendritic cells in cancer immunotherapy. Annu Rev Immunol (2000) 2.11
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med (2002) 2.07
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity (1999) 2.06
Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol (2000) 1.74
Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity (2003) 1.58
Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med (2003) 1.49
Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res (2000) 1.46
Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol (2000) 1.45
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res (2004) 1.42
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med (2000) 1.41
Strategies for immunotherapy of cancer. Adv Immunol (2000) 1.36
Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol (1995) 1.29
Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol (2000) 1.28
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Res (2003) 1.27
Synergy between tumor immunotherapy and antiangiogenic therapy. Blood (2003) 1.23
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J Immunol (2003) 1.22
Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med (2000) 1.22
The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur J Immunol (2000) 1.19
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses. J Clin Oncol (2003) 1.17
Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med (2002) 1.16
Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother (2003) 1.07
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunol Immunother (2004) 1.02
Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. J Interferon Res (1994) 1.01
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta (1999) 1.01
Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells. Cancer Res (1998) 0.98
Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res (2002) 0.98
RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol (2003) 0.97
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res (2003) 0.94
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells. J Immunol (2003) 0.93
Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model. Br J Haematol (2003) 0.93
Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur J Immunol (2000) 0.91
Processing and presentation of antigens by dendritic cells: implications for vaccines. Trends Mol Med (2001) 0.82
Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen. Immunol Today (1998) 0.79
Nonmyeloablative stem cell transplantation for chronic myeloid leukemia. Hematol Oncol Clin North Am (2004) 0.76
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83
Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys (2010) 3.73
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 3.61
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2002) 2.76
Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol (2007) 2.56
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J (2008) 2.27
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer (2003) 2.24
Telomeric expression sites are highly conserved in Trypanosoma brucei. PLoS One (2008) 2.22
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol (2008) 2.08
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys (2005) 2.02
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys (2009) 1.97
Equatorially dominated magnetic field change at the surface of Earth's core. Science (2003) 1.94
GeneDB--an annotation database for pathogens. Nucleic Acids Res (2011) 1.82
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev Cell (2010) 1.64
Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer (2005) 1.57
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.56
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
A novel small-angle neutron scattering detector geometry. J Appl Crystallogr (2013) 1.39
Estimating the volume of chronic pleural effusions using transesophageal echocardiography. J Cardiothorac Vasc Anesth (2011) 1.39
An autonomous implantable computer for neural recording and stimulation in unrestrained primates. J Neurosci Methods (2005) 1.38
Learning a novel myoelectric-controlled interface task. J Neurophysiol (2008) 1.36
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer (2006) 1.28
Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med (2011) 1.22
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Flexible cortical control of task-specific muscle synergies. J Neurosci (2012) 1.14
Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. J Biol Chem (2010) 1.12
Reanimating the arm and hand with intraspinal microstimulation. J Neural Eng (2011) 1.12
The finished DNA sequence of human chromosome 12. Nature (2006) 1.08
Intensity-modulated radiotherapy. Cancer J (2002) 1.07
Slower Walking Speed Forecasts Increased Postoperative Morbidity and 1-Year Mortality Across Surgical Specialties. Ann Surg (2015) 1.07
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Surgical Ward Round Quality and Impact on Variable Patient Outcomes. Ann Surg (2015) 1.07
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics (2012) 1.05
Increased water retention in polymer electrolyte membranes at elevated temperatures assisted by capillary condensation. Nano Lett (2007) 1.04
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys (2006) 1.04
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01
Abstract and proportional myoelectric control for multi-fingered hand prostheses. Ann Biomed Eng (2013) 1.01
Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2012) 1.00
Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol (2003) 1.00
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol (2002) 1.00
Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics (2012) 0.99
Thrombotic microangiopathy associated with interferon beta. N Engl J Med (2014) 0.97
Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.95
Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol (2009) 0.95
The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res (2010) 0.95
Reduced-order parameter optimization for simplifying prostate IMRT planning. Phys Med Biol (2007) 0.94
Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development (2012) 0.94
Secondary prevention interventions for young drug users: a systematic review of the evidence. Adolescence (2005) 0.93
Characterization of human pancreatic progenitor cells. Cell Transplant (2010) 0.93
Comparison of ulinastatin, gabexate mesilate, and nafamostat mesilate in preservation solution for islet isolation. Cell Transplant (2012) 0.92
SUITO index for evaluation of efficacy of single donor islet transplantation. Cell Transplant (2009) 0.92
CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary. Dev Biol (2006) 0.92
Ductal injection of JNK inhibitors before pancreas preservation prevents islet apoptosis and improves islet graft function. Hum Gene Ther (2009) 0.92
Reduced-order constrained optimization in IMRT planning. Phys Med Biol (2008) 0.90
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials (2011) 0.90
Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus. FEMS Microbiol Lett (2011) 0.89
Comparison of modified Celsior solution and M-kyoto solution for pancreas preservation in human islet isolation. Cell Transplant (2010) 0.89
Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent) (2007) 0.89
Rectal motion can reduce CTV coverage and increase rectal dose during prostate radiotherapy: A daily cone-beam CT study. Radiother Oncol (2008) 0.89
Dosimetric effect of respiratory motion in external beam radiotherapy of the lung. Radiother Oncol (2004) 0.88
Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor. Bioorg Med Chem Lett (2012) 0.88
Electromagnetically driven westward drift and inner-core superrotation in Earth's core. Proc Natl Acad Sci U S A (2013) 0.88
Upper-limb muscle responses to epidural, subdural and intraspinal stimulation of the cervical spinal cord. J Neural Eng (2014) 0.87
Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases. Int J Radiat Oncol Biol Phys (2010) 0.87
A note on the probability distribution function of the surface electromyogram signal. Brain Res Bull (2012) 0.87
Transesophageal echocardiographic imaging of the branches of the aorta: a guide to obtaining these images and their clinical utility. J Cardiothorac Vasc Anesth (2009) 0.87
(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys (2008) 0.86
A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization. Med Phys (2005) 0.86
Greater intermanual transfer in the elderly suggests age-related bilateral motor cortex activation is compensatory. J Mot Behav (2015) 0.86
Reduced order constrained optimization (ROCO): clinical application to lung IMRT. Med Phys (2011) 0.86
Estimation of donor usability for islet transplantation in the United States with the kyoto islet isolation method. Cell Transplant (2009) 0.85
Coaxial electrohydrodynamic spraying: a novel one-step technique to prepare oligodeoxynucleotide encapsulated lipoplex nanoparticles. Mol Pharm (2009) 0.85
Functional analysis of the SRY-KRAB interaction in mouse sex determination. Biol Cell (2009) 0.83
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice. Mol Ther Nucleic Acids (2013) 0.83
Stereotactic body radiation therapy for primary lung cancers >3 centimeters. J Thorac Oncol (2013) 0.83
Islet cell transplantation for the treatment of type 1 diabetes in the USA. J Hepatobiliary Pancreat Surg (2008) 0.82
Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors. Bioorg Med Chem Lett (2011) 0.82
High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated. Int J Radiat Oncol Biol Phys (2004) 0.81
A male-specific role for p38 mitogen-activated protein kinase in germ cell sex differentiation in mice. Biol Reprod (2010) 0.81
Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer. Med Phys (2008) 0.81
Renal function, uraemia and early arteriovenous fistula failure. BMC Nephrol (2014) 0.81
The influence of curvature on membrane domains. Eur Biophys J (2008) 0.80
High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer. Cancer J (2007) 0.80
False aneurysm of a hepatic artery branch complicating intrahepatic islet transplantation. Transpl Int (2009) 0.79
The DNA sequence, annotation and analysis of human chromosome 3. Nature (2006) 0.78
Antigenic targets for renal cell carcinoma immunotherapy. Expert Opin Biol Ther (2004) 0.78
Reduced-order constrained optimization (ROCO): clinical application to head-and-neck IMRT. Med Phys (2013) 0.78
Adapting proportional myoelectric-controlled interfaces for prosthetic hands. Conf Proc IEEE Eng Med Biol Soc (2013) 0.78
The detection and measurement of interleukin-6 in venous and capillary blood samples, and in sweat collected at rest and during exercise. Eur J Appl Physiol (2014) 0.77
Small angle scattering model for Pickering emulsions and raspberry particles. J Colloid Interface Sci (2009) 0.77
Artificial proprioceptive feedback for myoelectric control. IEEE Trans Neural Syst Rehabil Eng (2014) 0.77